NCT01254903

Brief Summary

The goal of this clinical study is to learn the feasibility of using a single session of radiation, known as spine stereotactic radiosurgery (SSRS), to treat metastatic epidural spinal cord compression.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P50-P75 for phase_1

Timeline
11mo left

Started Dec 2010

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Dec 2010Apr 2027

First Submitted

Initial submission to the registry

December 3, 2010

Completed
Same day until next milestone

Study Start

First participant enrolled

December 3, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 7, 2010

Completed
16.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

16.3 years

First QC Date

December 3, 2010

Last Update Submit

April 13, 2026

Conditions

Keywords

Stereotactic RadiosurgeryRadiationRadiotherapyMetastatic Epidural Spinal Cord CompressionMESCC

Outcome Measures

Primary Outcomes (1)

  • Number of Occurrences of Paralysis caused by Radiation Myelitis (RM)

    Incidence of patients who are ambulatory at baseline, 3 months and 6 months will be tabulated. Cases of patients who develop spinal cord myelopathy determined to be radiation related graded according to NCI CTC v4.0 scale.

    Up to 12 months following radiation

Study Arms (1)

Stereotactic Radiosurgery (SSRS)

EXPERIMENTAL

Target dose of 18 or 24 Gy to spine in single session of radiation treatment.

Procedure: Stereotactic Radiosurgery (SSRS)

Interventions

Target dose of 18 or 24 Gy to spine in single session of radiation treatment.

Also known as: Radiotherapy, Radiation therapy
Stereotactic Radiosurgery (SSRS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Greater than or equal to 18 years old
  • Radiographically documented metastatic epidural compression on spine Magnetic resonance imaging (MRI) within 4 weeks of registration, defined radiographically, ranging from minimal canal compromise and thecal indentation to actual displacement of the spinal cord.
  • Maximum of 3 contiguous vertebral levels involved with metastasis in the spine to be irradiated in a single session
  • Signed Informed consent

You may not qualify if:

  • Motor Strength \>/= 4 out of 5 in extremity or extremities affected by the level of the spinal cord compression
  • Karnofsky performance status (KPS) \>/= 40
  • Patients deemed to be inoperable by patient refusal, by neurosurgical evaluation, or for any reason
  • Patient with radiosensitive histologies (lymphoma, multiple myeloma, small cell carcinoma, germ cell tumors) as conventional radiation is likely to be effective
  • Prior irradiation of the spine site and level to be treated
  • Inability to tolerate lying flat on treatment table for greater than 30 minutes.
  • Patients unable to undergo MRI of the spine
  • Patients who are pregnant
  • Patients who have cord compression from bone components or configuration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Interventions

RadiosurgeryRadiotherapy

Intervention Hierarchy (Ancestors)

TherapeuticsStereotaxic TechniquesNeurosurgical ProceduresSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Amol J. Ghia, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2010

First Posted

December 7, 2010

Study Start

December 3, 2010

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

April 16, 2026

Record last verified: 2026-04

Locations